Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2025-12-24 @ 11:18 PM
NCT ID:
NCT00969956
Eligibility Criteria:
Inclusion Criteria:
* Diabetes type 1, 2 or LADA: 18-75 years of age.
* Group A: 150 Type 1 Diabetes, duration 15 years (+/-2 years) and 150 Type 2
* Diabetes 2 years (+/-2 years) (50% F/M)
* Group B: 150 Type 1 Diabetes, duration 20 years (+/-2 years) and 150 Type 2
* Diabetes 7 years (+/-2 years) (50% F/M)
* Group C: 150 Type 1 Diabetes, duration 25 years (+/-2 years) and 150 Type 2
* Diabetes 12 years (+/-2 years) (50% F/M)
* Group D: 50 LADA, onset after 35 years of age, duration of 5-10 years (50% F/M)
* Type 1 Diabetes: Positive ICA antibodies and/or GAD-antibodies and/or neg C-peptide. Debut \<30 years of age.
* Type 2 Diabetes: Negative ICA-antibodies and GAD-antibodies and pos C-peptide (\>0.35 mmol/l).
* LADA: Positive ICA-antibodies and/or GAD-antibodies. Debut \>35 years of age.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT00969956
Study Brief:
Protocol Section:
NCT00969956